ACW actinogen medical limited
Add to My Watchlist 0.00% ! 2.0¢

Ann: ACW randomizes first US participant in Alzheimers trial, page-19

  1. IndexInvestor
    9,027 Posts.
    lightbulb Created with Sketch. 1472
    clock Created with Sketch.
    14/12/24
    04:12
    Post #: 77046222
    Having trials in the US also means it's closer to home for the FDA and for any US insto investor, not only BP.
    (A US insto knows perfectly well how to buy on the ASX; no need for a US listing.)
    ACW Price at posting: 2.8¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS FBR Executes Engineering Service Agreement with Samsung Heavy Industries
right-arrow Created with Sketch.
NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
VMM Viridis Selected for BNDES and FINEP Strategic Mineral Funding to Advance Colossus Project
right-arrow Created with Sketch.
NEWS Bonanza Dittmer Drilling Hits 221g/t Gold in Stage 5 Intersection
right-arrow Created with Sketch.
NEWS Ministerial Approval Grants Provisional Authorisation for Battery Anode Material Facility
right-arrow Created with Sketch.
NEWS High-Grade Gold Hits Extend Major Lodes at Kpali Prospect in Ghana
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $63.54M
Open High Low Value Volume
2.1¢ 2.1¢ 1.9¢ $89.16K 4.345M

Buyers (Bids)

No. Vol. Price($)
2 930170 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 694274 3
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.